Effect Modification and Interaction in Veterinary Epidemiology

By Dr. Zubair Khalid, DVM, MS, PhD · 2026-08-11

Key Takeaways

• Effect modification occurs when the magnitude or direction of an exposure-outcome association differs across levels of a third variable (e.g., breed, age, vaccination status), necessitating the reporting of stratum-specific estimates rather than a single pooled measure.
• Statistical interaction, distinct from effect modification, quantifies a departure from additivity or multiplicativity of effects on a chosen scale (risk difference or risk ratio/odds ratio), requiring product terms in regression models for assessment.
• Confounding distorts the exposure-outcome association due to unequal distribution of a third variable across exposure groups and requires adjustment or stratification to remove bias, whereas effect modification describes a property of the causal system itself.
• Stratified analysis is the primary tool for detecting effect modification by estimating the exposure-outcome association within distinct levels of a potential modifier (e.g., parity in dairy cows for ketosis risk), with comparisons of stratum-specific estimates informing clinical decisions.
• The scale of measurement (additive vs. multiplicative) is critical, as interaction may be present on one scale but absent on another; the additive scale is often more relevant for public health impact (e.g., number of cases prevented), while the multiplicative scale is common in logistic regression.
• Gene-environment interactions, where genetic variants (e.g., breed, specific gene alleles) modify responses to environmental exposures (e.g., nutritional interventions, infectious agents), are crucial in veterinary research but require substantial sample sizes for detection.

Epidemiologic associations in animal populations rarely operate uniformly across all individuals. A risk factor that strongly predicts disease in one subgroup may have little effect in another, and two exposures together may produce a burden that neither would produce alone. This article explains effect modification and interaction as distinct analytic concepts in veterinary epidemiology, provides the study-design logic and stratified analytic framework needed to detect them, and distinguishes these phenomena from confounding. It is written for veterinary researchers, graduate students in population medicine, and clinicians who interpret the observational literature that informs herd health and evidence-based practice.

The central question this article answers is practical: when does a single measure of association mislead, and how can the investigator characterize the conditions under which an exposure acts? Effect modification describes a situation in which the magnitude or direction of an exposure-outcome association differs across levels of a third variable. Interaction, in the statistical sense, refers to a departure from additivity or multiplicativity of effects on the chosen scale. Both phenomena carry direct consequences for prevention, treatment allocation, and risk communication in animal populations, from dairy herd mastitis control to wildlife disease surveillance.

At a Glance

Conceptual Foundations

Effect modification arises when a biological or environmental condition alters susceptibility to an exposure. The modifier is not a nuisance to be adjusted away, it is a feature of the causal system that must be reported. In veterinary medicine, age, sex, breed, body condition, co-infection status, vaccination history, and management system frequently modify exposure effects. For example, a nutritional intervention may reduce lameness only in animals with high genetic merit for milk production, or an anthelmintic program may lower parasite burden only in young stock with limited prior exposure.

The distinction between effect modification and confounding is fundamental. A confounder is associated with both exposure and outcome and lies on a causal pathway that distorts the estimate of interest. Adjustment for confounding is always appropriate. Effect modification, by contrast, is a property of the exposure-outcome relation itself. The modifier does not create bias, it defines the conditions under which the exposure acts. Adjusting for an effect modifier by including it only as a covariate produces a single averaged estimate that obscures meaningful subgroup differences. The investigator must decide, on biological grounds, whether a third variable is a confounder, an effect modifier, or both. A variable can be both, as when age confounds an association because older animals are both more exposed and more diseased, while also modifying the effect because older animals respond differently to the exposure.

The Scale Question

Whether interaction is present depends on the scale of measurement. An interaction detected on the additive scale may disappear on the multiplicative scale, and vice versa. The additive scale compares risk differences: the excess risk attributable to exposure in one stratum versus another. The multiplicative scale compares risk ratios or odds ratios. Public health impact is best judged on the additive scale, because absolute risk reduction determines the number of animals that must be treated to prevent one case. Relative measures, however, are the default output of logistic and Cox regression, and multiplicative interaction is what a product term in these models tests.

This scale dependence is not a technical nuisance. It reflects a substantive question: does the investigator care whether the exposure adds a constant amount of risk across subgroups, or whether it multiplies risk by a constant factor? Both questions are legitimate, but they are different questions. A study reporting no interaction on the multiplicative scale may still show important differences in absolute risk, and a study reporting interaction on the multiplicative scale may show parallel risk differences across strata. The choice of scale should be specified before analysis and justified by the decision the study is meant to inform.

Stratified Analysis

Stratified analysis is the foundational method for examining effect modification. The investigator estimates the exposure-outcome association separately within each level of the potential modifier and compares the stratum-specific estimates. If the estimates differ meaningfully, effect modification is present. The comparison should consider both the point estimates and their confidence intervals. Overlapping confidence intervals do not prove the absence of interaction, because stratum-specific estimates are imprecise when sample sizes are small. Formal tests of homogeneity, such as the Breslow-Day test for odds ratios, have limited power and should be interpreted alongside the magnitude and direction of the stratum-specific estimates.

The CDC principles of epidemiology in public health practice describe stratified analysis as a core technique for evaluating whether an association is consistent across population subgroups. In veterinary applications, strata are often defined by species, breed, age class, production stage, or herd type. A stratified analysis of a vaccine field trial might estimate vaccine efficacy separately for young and adult animals, for animals with and without maternal antibody, or for animals in high- and low-challenge environments. Each stratum-specific estimate answers a distinct clinical question.

Regression Approaches

In regression models, effect modification is examined by including a product term between the exposure and the potential modifier. In a logistic model, the coefficient for the product term estimates the departure from multiplicativity of odds ratios. In a linear model, the product term estimates the departure from additivity of mean differences. The interpretation of the main effects changes once a product term is included: the coefficient for exposure now represents the effect of exposure when the modifier equals zero, and the coefficient for the modifier represents its effect when exposure equals zero. Centering continuous modifiers improves interpretability.

Model selection for interaction terms should be guided by biological plausibility and prespecified hypotheses instead of stepwise algorithms. Multiple testing inflates the risk of false-positive interactions, particularly when many candidate modifiers are screened. The methodological issues in studies of air pollution and reproductive health highlight how inconsistent findings across studies can arise from differences in how effect modification is modelled and reported, and they recommend parallel analyzes of existing data sets using standardized approaches. Veterinary researchers should pre-register their interaction hypotheses where feasible and report all interactions examined, also those that reached statistical significance.

Reporting and Interpretation

Effect modification should be reported with stratum-specific estimates and confidence intervals, the scale on which interaction was assessed, and the test used. A single p-value for interaction is insufficient. The reader needs to see the pattern of effects across strata to judge clinical relevance. Confidence intervals for stratum-specific estimates convey precision, and the interaction test conveys whether the differences could be due to chance. Both are needed.

The WOAH animal health surveillance standards emphasize that surveillance data must be interpreted in light of population structure and subgroup differences. Effect modification is not a statistical arteifact to be eliminated but a biological signal to be understood. When an exposure appears protective in one subgroup and harmful in another, the averaged estimate may be null, and a conclusion of no effect would be wrong for both subgroups. Reporting effect modification is therefore an ethical obligation in veterinary research, because it determines which animals benefit from an intervention and which may be harmed.

Worked Example: Stratified Analysis in a Veterinary Cohort

Consider a hypothetical prospective cohort study of 1,200 adult dairy cows followed across one lactation to estimate the association between subclinical ketosis in the first 2 weeks postpartum and risk of clinical metritis within 30 days. The crude risk ratio is 2.1 (95% CI 1.6 to 2.8). The investigator suspects that parity modifies this association, because primiparous animals have different metabolic demands and immune profiles than multiparous animals.

The analysis proceeds in four steps. First, the exposure-outcome association is estimated within each stratum of parity. Second, the stratum-specific estimates are compared visually and statistically. Third, a test of homogeneity is applied. Fourth, the investigator decides whether to report stratum-specific estimates or a single adjusted estimate.

Table 1 shows the stratum-specific results.

The stratum-specific risk ratios differ materially. The test of homogeneity (Breslow-Day) yields p = 0.003, supporting the visual impression that parity modifies the effect. The crude estimate of 2.1 falls between the two stratum-specific values, which is typical when effect modification is present. Reporting a single adjusted estimate would obscure the clinically relevant finding that multiparous cows carry a substantially higher risk increment from ketosis than primiparous cows.

The interpretation changes the clinical response. In this herd, monitoring protocols for ketosis should be prioritized in multiparous cows, and the threshold for intervention may need to be lower in that group. The stratum-specific estimates also inform sample size calculations for a future intervention trial, because the expected treatment benefit will differ by parity.

Interaction on the Additive and Multiplicative Scales

Effect modification is scale-dependent. A single dataset can show interaction on one scale but not on another, and the choice of scale should follow the research question. The multiplicative scale is the default output of logistic and Cox regression, where the exponentiated coefficient for a product term tests whether the ratio of risks or hazards differs across strata. The additive scale asks whether the absolute risk difference differs, and it is often more relevant for public health and clinical decision making because it reflects the actual number of cases that could be prevented.

For the ketosis example, the additive interaction can be assessed by calculating the relative excess risk due to interaction (RERI). If the joint effect of ketosis and multiparity exceeds the sum of their individual effects, RERI is positive. Confidence intervals for RERI are wide in most veterinary datasets, and the estimate should be interpreted cautiously when stratum-specific counts are small.

Regression models with product terms are the standard approach for assessing interaction in multivariable settings. The product term coefficient tests the null hypothesis that the effect is constant across levels of the modifier. A statistically significant product term supports effect modification, but the absence of significance does not prove homogeneity, particularly in studies with limited power. The confidence interval around the interaction term should be examined directly. A wide interval that includes clinically meaningful values on both sides of the null is uninformative, and the investigator should report it as such.

Gene-Environment Interaction in Animal Health Research

Genetic modifiers of environmental exposures are a recurring theme in the epidemiological literature on air pollution and human health. Studies of particulate matter and plasma homocysteine have shown that variants in oxidative stress pathway genes, including GSTT1 and HFE C282Y, modify the association between black carbon exposure and homocysteine levels Ren et al., air pollution and homocysteine gene modification. The same methodological logic applies to veterinary populations, where breed, line, or individual genetic variants may modify responses to nutritional, infectious, or environmental exposures.

In veterinary data, gene-environment interaction is often approached through stratified analysis by genotype or breed, followed by a product term in regression. The practical constraints are substantial. Genotype data are expensive to collect, and most veterinary cohorts are too small to detect interaction effects of realistic magnitude. A study designed to detect a main effect of 1.5 will typically need four times the sample size to detect an interaction of the same magnitude. Investigators should state the detectable interaction effect size in the protocol and avoid overinterpreting null interaction tests from underpowered samples.

Effect Modification by Host Characteriztics

Host characteriztics are the most common effect modifiers in veterinary studies. Age, sex, breed, body condition, pregnancy status, and co-morbidity all have plausible biological roles in modifying exposure effects. The choice of modifier should be driven by mechanism, not by convenience. A modifier with no biological rationale risks producing spurious findings through multiple testing.

The Rancho Bernardo study of protein consumption and bone mineral density illustrates the pattern of a modifier that is identified post hoc and reported with appropriate caution. The authors found that the association between animal protein and bone density was stronger in women with lower calcium intake, but they noted that the evidence for this interaction was not consistently strong across skeletal sites Promislow et al., protein consumption and bone mineral density. This is a model for reporting: the stratum-specific estimates are shown, the interaction test is reported, and the uncertainty is acknowledged.

In veterinary practice, the same reasoning applies to decisions about therapeutic protocols. A drug that is effective in young adult animals may show a different risk-benefit profile in geriatric patients with reduced renal clearance. The effect modifier is age, and the clinical response is to adjust monitoring frequency or dose selection. Current formulary and label references must be consulted for species-specific dosing guidance, because extrapolation across species is a common source of error.

Interaction in Surveillance and Outbreak Response

Surveillance standards from the World Organization for Animal Health emphasize that surveillance systems must be fit for purpose and that the interpretation of surveillance data depends on the production system and the epidemiological context WOAH animal health surveillance standards. Effect modification enters surveillance design when the sensitivity of a diagnostic test or the probability of clinical detection varies by species, age class, or production stage.

For example, a surveillance program for a respiratory pathogen in feedlot cattle will have different test characteriztics in recently arrived calves compared with animals that have been on feed for several months. The prevalence of clinical signs differs, and the predictive value of a positive test changes accordingly. Stratified reporting by production stage is therefore a form of effect modification management, even when no formal interaction test is performed.

The terrestrial animal health code provides the international framework for surveillance and trade-related decision making WOAH terrestrial animal health code. When surveillance data are used to support freedom from disease claims, the analysis must account for effect modification by production system, because a single pooled estimate may misrepresent the risk in specific subpopulations.

Documentation and Reporting Standards

The reporting of effect modification should follow a consistent structure. State the modifier and its biological rationale before the analysis. Present stratum-specific estimates with confidence intervals. Report the interaction test and its p value. State whether the interaction is on the additive or multiplicative scale. If the interaction is not significant, report the confidence interval for the interaction term instead of relying on the p value alone.

The CDC principles of epidemiology emphasize that the interpretation of any association requires consideration of whether the effect is consistent across subgroups CDC principles of epidemiology. This applies to veterinary investigations as much as to human public health. A finding that is present in one subgroup and absent in another should be reported as such, because the pooled estimate may be misleading for clinical decision making.

Species differences are a particular concern in veterinary epidemiology. An effect modifier identified in one species cannot be assumed to operate in another. The biological basis of the modification must be assessed independently for each species, and the reporting should make clear which species and production systems the findings apply to.

Recognized Failure Modes and Early Detection

Effect modification analyzes fail in predictable ways. The most common failure is the conflation of effect modification with confounding, which produces correct statistical output but an incorrect research question. Confounding asks whether the exposure-outcome association is distorted by a third variable. Effect modification asks whether the association itself differs across levels of a third variable. The distinction is visible in the analysis plan: confounders are adjusted, modifiers are stratified or interacted. A study that adjusts for a true modifier attenuates the very signal it seeks to describe.

A second failure mode is the detection of interaction where none exists, driven by multiple testing. Screening dozens of candidate modifiers without prespecification inflates the false-positive rate. The problem is compounded in veterinary datasets with modest sample sizes, where stratum-specific estimates carry wide confidence intervals and apparent differences between strata arise by chance. Early detection requires a prespecified analysis plan that names the candidate modifiers, the direction of expected effect, and the statistical threshold for claiming interaction. The CDC principles of epidemiology in public health practice emphasize that stratified analysis is a descriptive exercise first and an inferential one second, the stratum-specific estimates and their confidence intervals should be examined before any formal test is interpreted.

A third failure mode is the ecological fallacy applied to interaction. When individual-level data are unavailable, researchers sometimes infer effect modification from group-level comparisons. This is particularly tempting in production animal medicine, where herd-level data are easier to obtain than animal-level records. The inference is invalid because group-level associations do not describe individual-level modification. The methodological issues raised in air pollution and reproductive health research apply directly here: variability in findings across studies often reflects differences in the level of aggregation, not true biological modification.

Common Errors and Corrective Action

Less experienced analysts frequently test for interaction on only one scale. A multiplicative-scale interaction term in a logistic or Cox model may be null while an additive-scale interaction is present, or vice versa. The corrective action is to report both. The distinction is not academic. In a study of arsenic exposure and liver injury, the association between arsenic and nonalcoholic fatty liver disease was modified by race and ethnicity, and the interpretation of that modification depended on whether the research question concerned relative or absolute risk. The same principle governs veterinary studies: a vaccine that reduces relative risk uniformly across breeds may still produce different absolute risk reductions if baseline risk differs.

A second common error is the interpretation of a marginal interaction test as evidence that all strata are homogeneous. A nonsignificant interaction term does not prove the absence of effect modification. It may reflect inadequate power within strata. The corrective action is to present stratum-specific estimates with confidence intervals and to judge clinical importance alongside statistical significance. The Rancho Bernardo study of protein consumption and bone mineral density illustrates the point: the authors found suggestive evidence of modification by calcium intake, but the evidence was not consistently strong, and they reported it as such instead of forcing a conclusion.

A third error is the treatment of a modifier as a confounder because it is associated with both exposure and outcome. This error is common when the modifier is measured at baseline and the analyst adjusts for it in a single model. The corrective action is to ask whether the variable lies on the causal pathway or represents a distinct biological subgroup. If it is a subgroup characteriztic, such as breed, sex, or age class, stratification or an interaction term is the appropriate tool.

Limitations of Current Evidence

The veterinary evidence base for effect modification is thinner than the human literature. Most veterinary studies are powered to detect main effects, not interactions, and the sample sizes required to detect modification are substantially larger. A study designed to detect a main effect with 80% power may have less than 50% power to detect a meaningful interaction. This limitation is rarely acknowledged in the discussion sections of veterinary papers.

Expert opinion differs on the threshold for claiming interaction. Some epidemiologists require a statistically significant product term, others accept a meaningful difference in stratum-specific estimates even when the product term is not significant. The klotho and mortality analysis found effect modification by physical activity, but the authors noted that associations did not differ by most participant characteriztics, a pattern that is common in practice. The honest interpretation is that most candidate modifiers will not modify the effect, and the ones that do require replication.

Species differences compound the problem. A modifier identified in one species may not transfer to another because of differences in physiology, management, or baseline disease risk. The WOAH terrestrial animal health standards require surveillance data that are comparable across production systems, but comparability does not guarantee that effect modification patterns will be consistent across those systems.

Escalation and Referral

Most effect modification analyzes can be handled within a well-designed observational study. Escalation is warranted when the analysis will inform regulatory decisions, trade policy, or intervention strategies at the population level. In those circumstances, consultation with a veterinary epidemiologist or biostatistician is appropriate before the analysis plan is finalised, not after the results are in.

Laboratory involvement is indicated when the candidate modifier is a biomarker, a genotype, or an assay-dependent measurement. The gene-environment interaction work on air pollution and homocysteine required genotyping and repeated exposure measurement, and the validity of the interaction depended on the reliability of both. In veterinary practice, the same principle applies to genetic testing for production traits, diagnostic assays for subclinical disease, and any laboratory measure that will be used as a stratification variable.

Regulatory reporting is required when effect modification changes the interpretation of a notifiable disease investigation. If a surveillance program detects a pathogen and the risk of clinical disease differs by species, age, or production type, the WOAH animal health surveillance standards require that the reporting reflect those differences. Failure to report modification can lead to inappropriate risk assessments and misdirected control measures.

Troubleshooting Table

Frequently Asked Questions

How Do I Decide Whether to Test for Effect Modification When My Sample Size Is Limited?

With limited sample size, test only for effect modifiers with strong prior biological plausibility, not every available covariate. Prespecify one or two candidate modifiers in the study protocol. Use stratified analysis first, because it is transparent and does not require the distributional assumptions of interaction terms in regression models. If strata become too sparse for stable estimates, fit a single regression model with one interaction term and report the confidence interval around the interaction coefficient. A wide confidence interval that includes the null does not prove absence of effect modification, it reflects low power. Interpret such results cautiously and describe them as inconclusive instead of negative.

What Should I Do When Stratified Estimates Differ Visually but the Interaction Test Is Not Significant?

Visual differences in stratum-specific estimates can arise from sampling variability, especially with small strata. The interaction test formally evaluates whether the observed differences exceed what chance alone would produce. When the test is not significant, report the stratum-specific estimates and the interaction p-value together, and avoid claiming effect modification. Consider whether the scale of measurement is appropriate. A difference that is not significant on the multiplicative scale may still be meaningful on the additive scale, and vice versa. If the evidence base supports a biological rationale, describe the pattern as suggestive and recommend confirmation in a larger or pooled dataset.

How Does Effect Modification Change My Approach in a Multi-Species Practice?

Species differences in physiology, metabolism, and management mean that an effect modifier identified in one species cannot be assumed to transfer to another. For example, age, sex, and body condition may modify associations differently in cattle than in companion animals. When designing a study across species, include species as a candidate effect modifier and test interaction terms explicitly instead of adjusting for species as a confounder. Adjusting for species forces a single pooled estimate, which obscures stratum-specific effects. In clinical practice, apply published interaction findings only to the species and production system in which they were derived, and consult species-specific references such as the MSD Veterinary Manual for context on relevant biological pathways.

What Are the Practical Costs of Ignoring Effect Modification in an Outbreak Investigation?

Ignoring effect modification during an outbreak can misdirect control measures. If a risk factor operates only in a specific subpopulation, pooled estimates dilute the association and may lead to a false conclusion that the factor is unimportant. Conversely, a factor that appears weakly associated overall may be strongly associated in one group, and failing to identify that group delays targeted intervention. Surveillance standards from the World Organization for Animal Health emphasize that surveillance data should support stratified reporting where relevant. The cost is also statistical, it is operational. Resources spent on blanket interventions may miss the high-risk group entirely while over-treating low-risk groups.

How Should I Document Effect Modification Analyzes in a Clinical or Research Record?

Document the prespecified candidate modifiers, the analytic approach, and the results of interaction tests before the main effects are interpreted. Record the stratum-specific estimates with confidence intervals, the interaction p-values, and the scale on which the interaction was assessed. Note any decisions made after seeing the data, such as collapsing strata or changing the scale, because these affect the validity of the conclusions. In clinical records, document when a treatment or preventive measure is expected to work differently in a subpopulation and cite the evidence base. This supports continuity of care and defensible decision-making. The CDC principles of epidemiology provide a framework for documenting analytic decisions in outbreak and surveillance settings.

How Do I Explain Effect Modification to a Client or a Non-Epidemiologist Supervisor?

Use a concrete example from the species and condition at hand. State that the effect of the exposure depends on a third factor, and that the association is not the same in all groups. Avoid statistical terminology. For example, explain that a vaccine may protect young animals well but provide less protection in older animals with concurrent disease, so the decision to vaccinate should account for age and health status. Emphasize that this is not a flaw in the study, it is a real biological difference. If the interaction is uncertain, say so plainly and describe what additional data would clarify the picture. Professional practice resources from the American Veterinary Medical Association can help frame risk communication for lay audiences.

Related Clinical & Scientific Guides

• Evaluating Veterinary Surveillance System Attributes
• Network Analysis for Infectious Disease Spread in Animal Populations
• Randomized Controlled Trials in Veterinary Field Settings

References and Further Reading

• Methodological issues in studies of air pollution and reproductive health.. 2009.
• Arsenic exposure and risk of nonalcoholic fatty liver disease (NAFLD) among U.S. adolescents and adults: an association modified by race/ethnicity, NHANES 2005-2014.. 2018.
• Low Serum Klotho Associated With All-cause Mortality Among a Nationally Representative Sample of American Adults.. 2022.
• Protein consumption and bone mineral density in the elderly : the Rancho Bernardo Study.. 2002.
• Air pollution and homocysteine: more evidence that oxidative stress-related genes modify effects of particulate air pollution.. 2010.
• Dietary fat and weight gain among women in the Nurses' Health Study.. 2007.
• WOAH Animal Health Surveillance Standards. WOAH.
• CDC Principles of Epidemiology in Public Health Practice. CDC.
• MSD Veterinary Manual, Professional Edition. MSD Veterinary Manual.

Related Articles

• Using Simulation Models in Veterinary Epidemiology
• Basic Reproductive Ratio (R0) in Veterinary Epidemiology
• Spatio-Temporal Modeling of Animal Diseases
• Understanding Bias in Veterinary Epidemiological Studies
• Understanding Ecological Studies in Veterinary Epidemiology

This article is educational professional reference material for veterinary audiences. It is not a substitute for veterinary diagnosis, individual clinical judgment, current product labeling, or applicable regulatory requirements.